Hasselbalch HC - Search Results

1

Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b.

Kiladjian JJ, Klade C, Georgiev P, Krochmalczyk D, Gercheva-Kyuchukova L, Egyed M, Dulicek P, Illes A, Pylypenko H, Sivcheva L, Mayer J, Yablokova V, Krejcy K, Empson V, Hasselbalch HC, Kralovics R, Gisslinger H; PROUD-PV Study Group. Kiladjian JJ, et al. Among authors: hasselbalch hc. Leukemia. 2022 May;36(5):1408-1411. doi: 10.1038/s41375-022-01528-x. Epub 2022 Feb 24. Leukemia. 2022. PMID: 35210530 Free PMC article. No abstract available.

2

Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference.

Barosi G, Birgegard G, Finazzi G, Griesshammer M, Harrison C, Hasselbalch HC, Kiladjian JJ, Lengfelder E, McMullin MF, Passamonti F, Reilly JT, Vannucchi AM, Barbui T. Barosi G, et al. Among authors: hasselbalch hc. Blood. 2009 May 14;113(20):4829-33. doi: 10.1182/blood-2008-09-176818. Epub 2009 Mar 10. Blood. 2009. PMID: 19278953 Free article.

3

Interferon-alpha in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms. Status and perspectives.

Hasselbalch HC, Larsen TS, Riley CH, Jensen MK, Kiladjian JJ. Hasselbalch HC, et al. Curr Drug Targets. 2011 Mar 1;12(3):392-419. doi: 10.2174/138945011794815275. Curr Drug Targets. 2011. PMID: 21143149 Review.

4

Interferon alfa in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms.

Hasselbalch HC, Kiladjian JJ, Silver RT. Hasselbalch HC, et al. J Clin Oncol. 2011 Jun 20;29(18):e564-5. doi: 10.1200/JCO.2011.35.6238. Epub 2011 May 16. J Clin Oncol. 2011. PMID: 21576637 No abstract available.

5

Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms.

Skov V, Larsen TS, Thomassen M, Riley CH, Jensen MK, Bjerrum OW, Kruse TA, Hasselbalch HC. Skov V, et al. Among authors: hasselbalch hc. Leuk Lymphoma. 2012 Jan;53(1):123-9. doi: 10.3109/10428194.2011.597905. Epub 2011 Aug 1. Leuk Lymphoma. 2012. PMID: 21806350

6

Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: identification of deregulated genes of significance for inflammation and immune surveillance.

Skov V, Larsen TS, Thomassen M, Riley CH, Jensen MK, Bjerrum OW, Kruse TA, Hasselbalch HC. Skov V, et al. Among authors: hasselbalch hc. Leuk Res. 2012 Nov;36(11):1387-92. doi: 10.1016/j.leukres.2012.07.009. Epub 2012 Aug 9. Leuk Res. 2012. PMID: 22877729

7

Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?

Hasselbalch HC. Hasselbalch HC. Leuk Res. 2013 Feb;37(2):214-20. doi: 10.1016/j.leukres.2012.10.020. Epub 2012 Nov 20. Leuk Res. 2013. PMID: 23174192 Review.

8

Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis.

Skov V, Riley CH, Thomassen M, Larsen TS, Jensen MK, Bjerrum OW, Kruse TA, Hasselbalch HC. Skov V, et al. Among authors: hasselbalch hc. Leuk Lymphoma. 2013 Oct;54(10):2269-73. doi: 10.3109/10428194.2013.764417. Epub 2013 May 15. Leuk Lymphoma. 2013. PMID: 23302045

9

Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis.

Silver RT, Kiladjian JJ, Hasselbalch HC. Silver RT, et al. Among authors: hasselbalch hc. Expert Rev Hematol. 2013 Feb;6(1):49-58. doi: 10.1586/ehm.12.69. Expert Rev Hematol. 2013. PMID: 23373780

10

Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha.

Stauffer Larsen T, Iversen KF, Hansen E, Mathiasen AB, Marcher C, Frederiksen M, Larsen H, Helleberg I, Riley CH, Bjerrum OW, Rønnov-Jessen D, Møller MB, de Stricker K, Vestergaard H, Hasselbalch HC. Stauffer Larsen T, et al. Among authors: hasselbalch hc. Leuk Res. 2013 Sep;37(9):1041-5. doi: 10.1016/j.leukres.2013.06.012. Epub 2013 Jul 1. Leuk Res. 2013. PMID: 23827351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

299 results

Search Page